Superficial Radiation Theraphy
By delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless.
Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Best of all, it doesn’t involve cutting, bleeding or stitching. With the SRT-100™, there is no need for anesthesia, minimal risk of infection or scarring, no need for reconstructive plastic surgery. Patients heal quickly and don’t have downtime or lifestyle restrictions following treatment.
Sensus Healthcare’s SRT-100™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and multi-locale healthcare providers.
Superficial Radiation Theraphy offers hope to keloid sufferers.
SRT safety destroys the cells that form keloids, with over a 94% cure rate when used in combination with surgery. The SRT-100, SRT-100+ and SRT-100 Vision are FDA cleared for the treatment of keloids following surgical removal. Offering a keloid cure serves as an ideal base on which to build a strong footprint in the ethnic community.
